Searched for
MONOCLONAL ANTIBODY
Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facilityAurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines f...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Ebola outbreak declared emergency of international concern: What is it, how does it spread, and is there a vaccine?The World Health Organization has declared the Ebola outbreak in Democratic Republic of Congo and Uganda a global health emergency. The vir...
- Hantavirus scientists were close to vaccine but ran out of moneyScientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Aurobindo Pharma arm CuraTeQ gets Health Canada nod for biosimilarAurobindo Pharma announced a significant development today. Its subsidiary, CuraTeQ Biologics, has received a compliance notice from Health...
- India to procure 20 more doses of monoclonal antibody from Australia for Nipah treatment: ICMR DGIndia will procure an additional 20 doses of monoclonal antibody from Australia for the treatment of Nipah virus infection, according to Ra...
- Monoclonal antibody treatment combo keeps high-risk Covid patients out of hospital: StudyThe research enrolled nearly 1,400 patients, of whom 696 received the drug combo.
- Zydus Cadila, first Indian Company gets permission for clinical trials of antibodies cocktail to treat COVID-19: SourcesThe only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatm...
- 65 yr old man becomes 1st Covid patient to get antibody cocktail at Apollo in DelhiAs part of this single dose infusion-based treatment, patients with mild to moderate symptoms, are offered a cocktail of Casirivimab and Im...
- Fortis hospital in Delhi offers monoclonal antibody therapy; awaits takersAs part of this single dose infusion-based treatment, patients with mild to moderate symptoms are offered a cocktail of Casirivimab and Imd...
- WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivirThe WHO draft document, seen by Reuters and dated Oct. 30, says the priorities are to secure monoclonal antibodies in a tight market and to...
- New discovery: Antibody that may protect against COVID-19 infection identifiedThe researchers from the University of Massachusetts Medical School (UMMS) in the US discovered and characterised a cross-reactive human mo...
- What are antibody therapies and who is developing them for COVID-19?More recently, scientists have developed treatments called monoclonal antibodies -- antibodies that can be isolated and manufactured in lar...
- Bharat Bio leads CSIR project to develop human antibodiesThis programme brings together academia — National Centre for Cell Science, Indian Institute of Technology, Indore, and industry – PredOmix...
- Scientists create antibody that claims to defeat coronavirus in labMore research is needed to see whether the findings are confirmed in a clinical setting and how precisely the antibody defeats the virus.
- Rabishield: First fast-acting anti-rabies drug set for India launchRMAb has been developed by Pune-based Serum Institute of India (SII) and US-based Mass Biologics of the University of Massachusetts Medical...
- Glenmark Pharmaceuticals' new molecule enters human trialsGlenmark Pharmaceuticals S.A., a wholly owned Swiss subsidiary of Glenmark Pharmaceuticals, said GBR 830 is entering human trials.
- Glenmark Pharmaceuticals's monoclonal antibody for pain entering human trialsGBR 900 is a monoclonal antibody for the treatment of chronic pain targeting TrkA, the receptor of nerve growth factor (NGF).
- World's first anti-EGFR cancer antibody launchedBiotechnology behemoth Biocon has launched BIOMAb-EGFR, a therapeutic monoclonal antibody-based drug for treating solid tumours of epitheli...
Load More
